Medications like Ozempic, Wegovy, and Mounjaro, which are all part of the semaglutide class, are becoming increasingly popular for weight loss, especially among patients with obesity and weight-related health problems
GLP-1 supplements aim to support the natural production and release of GLP-1 hormone
Tier 3 requires a BMI of 27 or higher with prediabetes (or another Tier 3 condition), and a BMI of 31 meets that floor
Although these medications do have side effects, the side effects can be managed with dietary lifestyle changes that include low fat, high fiber foods, and a scientifically formulated dietary beverage like Biocare *
Several small clinical studies and case reports have documented significant reductions in hyperphagia and weight loss in PWS patients treated with GLP-1 agonists, though large-scale randomized trials are still limited
CrossRef Nutritional considerations for glucagon-like peptide-based therapies: An Asian Indian consensus recommendation Shashank R